Considering the importance of T-cell inflamed TME gene signatures driving TILs, as well as the potential impact of HDAC4 in regulating cancer growth and tumor immunity, the delineation of molecular mechanisms leading to reduced antitumor immune responses is of utmost significance. The gene discussed is HDAC4; the disease is neoplasm.